The beneficial effect of alpha-blockers for ureteral stent-related discomfort: Systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo Endourology and technology

BMC Urology

Volumn 15, Issue 1, 2015, Pages

  Kwon, Jong Kyou ^a   Cho, Kang Su ^b   Oh, Cheol Kyu ^a   Kang, Dong Hyuk ^c   Lee, Hyungmin ^d   Ham, Won Sik ^e   Choi, Young Deuk ^e   Lee, Joo Yong ^e  

^a Inje University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yangpyeong Health Center   (South Korea)

^d Korea Centers for Disease Control and Prevention   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Adrenergic alpha antagonists; Bayes theorem; Meta analysis; Stents; Ureter

Indexed keywords

ALFUZOSIN; PLACEBO; TAMSULOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; QUINAZOLINE DERIVATIVE; SULFONAMIDE;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS (TOPIC); PAIN ASSESSMENT; QUALITY CONTROL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SYSTEMATIC REVIEW; TREATMENT RESPONSE; URETER DISEASE; URETER STENT; URETERAL STENTING; URETERIC STENT SYMPTOMS QUESTIONNAIRE; ADVERSE EFFECTS; BAYES THEOREM; META ANALYSIS; PAIN; PAIN MEASUREMENT; STENT; TREATMENT OUTCOME; URETERAL OBSTRUCTION;

ADRENERGIC ALPHA-ANTAGONISTS; BAYES THEOREM; HUMANS; PAIN; PAIN MEASUREMENT; QUINAZOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; SULFONAMIDES; TREATMENT OUTCOME; URETERAL OBSTRUCTION;

EID: 84934984172     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/s12894-015-0050-5     Document Type: Article

References (28)

1. Finney RP. Experience with new double J ureteral catheter stent. J Urol. 1978;120(6):678-81.
2. Hepperlen TW, Mardis HK, Kammandel H. Self-retained internal ureteral stents: a new approach. J Urol. 1978;119(6):731-4.
3. Mendez-Probst CE, Fernandez A, Denstedt JD. Current status of ureteral stent technologies: comfort and antimicrobial resistance. Curr Urol Rep. 2010;11(2):67-73.
4. Chew BH, Lange D. Ureteral stent symptoms and associated infections: a biomaterials perspective. Nat Rev Urol. 2009;6(8):440-8.
5. Thomas R. Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol. 1993;7(2):137-40.
6. Lim KT, Kim YT, Lee TY, Park SY. Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol. 2011;52(7):485-8.
7. Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ. Meta-analysis showing the beneficial effect of alpha-blockers on ureteric stent discomfort. BJU Int. 2011;108(11):1894-902.
8. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331(7521):897-900.
9. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ. 2013;346:f2914.
10. Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-12.
11. Chung JH, Lee SW. Assessing the quality of randomized controlled urological trials conducted by korean medical institutions. Korean J Urol. 2013;54(5):289-96.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.
13. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials. 1986;7(4):267-75.
14. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7(8):889-94.
15. Beddingfield R, Pedro RN, Hinck B, Kreidberg C, Feia K, Monga M. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol. 2009;181(1):170-6.
16. Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology. 2006;67(1):35-9.
17. Nazim SM, Ather MH. Alpha-blockers impact stent-related symptoms: a randomized, double-blind, placebo-controlled trial. J Endourol Endourol So. 2012;26(9):1237-41.
18. Park SC, Jung SW, Lee JW, Rim JS. The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms. J Endourol. 2009;23(11):1913-7.
19. Wang CJ, Huang SW, Chang CH. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res. 2009;37(3):147-52.
20. Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D'Armiento M. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol. 2008;22(4):651-6.
21. Dellis AE, Keeley Jr FX, Manolas V, Skolarikos AA. Role of alpha-blockers in the treatment of stent-related symptoms: a prospective randomized control study. Urology. 2014;83(1):56-61.
22. Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P. Is there a role for alpha-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol. 2011;186(3):928-34.
23. Cha WH, Choi JD, Kim KH, Seo YJ, Lee K. Comparison and efficacy of low-dose and standard-dose tamsulosin and alfuzosin in medical expulsive therapy for lower ureteral calculi: prospective, randomized, comparative study. Korean J Urol. 2012;53(5):349-54.
24. Lang RJ, Exintaris B, Teele ME, Harvey J, Klemm MF. Electrical basis of peristalsis in the mammalian upper urinary tract. Clin Experimental Pharmacol Physiol. 1998;25(5):310-21.
25. Yoo TK, Cho HJ. Benign prostatic hyperplasia: from bench to clinic. Korean J Urol. 2012;53(3):139-48.
26. Andersson KE, Gratzke C. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol. 2007;4(7):368-78.
27. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ. 2000;320(7249):1574-7.
28. Lee SJ, Yoo C, Oh CY, Lee YS, Cho ST, Lee SH, et al. Stent position is more important than alpha-blockers or Anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic Ureterolithotomy: a prospective randomized study. Korean J Urol. 2010;51(9):636-41.